Field Technologies News

11. FDA Unveils Safe Use Initiative That Targets Preventable Harm From Medication Use 11/5/2009
    The U.S. Food and Drug Administration recently announced the Safe Use Initiative, a program aimed at reducing the likelihood of preventable harm from medication use.
12. Quintiles Announces Clinical Pharmacology Alliance With AstraZeneca 11/3/2009
    Quintiles today announced that it has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe.
13. Millipore Scientist To Lead PDA Web Seminar On Innovative Testing Methods For Detecting Mycoplasma Contamination 10/28/2009
    Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, will lead a web-based seminar on detection of Mycoplasma and viral contamination, a subject of heightened interest in biopharmaceutical manufacturing.
14. TransMolecular's ¹³¹I-Tm601 Shown To Improve Survival In Recurrent Malignant Glioma 10/26/2009

    TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, recently announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound ¹³¹I-TM601 in the treatment of recurrent malignant glioma.

15. Cozzoli Machine Company Special Machine Offer 10/23/2009
    Cozzoli Machine Company is pleased to offer our SW40 Stopper Washer as an in-stock special available for immediate delivery.
16. FDA Warns Of Unapproved And Illegal H1N1 Drug Products Purchased Over The Internet 10/19/2009
    The U.S. Food and Drug Administration today warned consumers to use extreme care when purchasing any products over the Internet that claim to diagnose, prevent, treat or cure the H1N1 influenza virus. The warning comes after the FDA recently purchased and analyzed several products represented online as Tamiflu (oseltamivir), which may pose risks to patients.
17. World Courier Triples Clinical Trial Storage Capacity Worldwide With Two New Facilities And Client-Driven Expansion 10/15/2009
    World Courier is pleased to announce the opening of its newest purpose-driven investigational drug storage facilities in Melbourne (Australia) and Johannesburg (South Africa), bringing its network of GMP (Good Manufacturing Practice)-compliant clinical trial depots to a total of 11 worldwide and providing cost-effective logistical access to two continents critical to the global pharmaceutical industry.
18. AMT Receives EMEA Orphan Drug Designation For Duchenne Muscular Dystrophy 10/14/2009
    Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced recently that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
19. Vical's TransVax™ CMV Vaccine Elicits Long-Term Immune Responses In Phase 2 Trial 10/12/2009
    Vical Incorporated announced today that the company's TransVax cytomegalovirus (CMV) vaccine continued to demonstrate an overall increase in cellular immune responses compared with placebo at the seven-month immunogenicity data point in an ongoing Phase 2 trial. Alain P. Rolland, Pharm.D., Ph.D., Vical's Executive Vice President of Product Development, presented the data today at the World Vaccine Congress (Lyon, France - October 5-8).
20. IMS Forecasts Global Pharmaceutical Market Growth Of 4 - 6% In 2010; Predicts 4 - 7% Expansion Through 2013 10/9/2009
    IMS Health reported recently that the value of the global pharmaceutical market in 2010 is expected to grow 4 - 6 percent on a constant-dollar basis, exceeding $825B, driven by stronger near-term growth in the U.S. market.